Table of Content



1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview

3. Market Dynamics
3.1. Key Drivers
3.1.1. Increasing Cellular Therapy Clinical Trials
3.1.2. Growth Of Regenerative Medicine
3.1.3. High Prevalence Of Chronic Diseases
3.2. Key Restraints
3.2.1. Increasing Skills Gap
3.2.2. High Costs

4. Key Analytics
4.1. Impact Of Covid-19 On Cell Therapy Market
4.2. Key Market Trends
4.3. Porter’S Five Forces Analysis
4.3.1. Buyers Power
4.3.2. Suppliers Power
4.3.3. Substitution
4.3.4. New Entrants
4.3.5. Industry Rivalry
4.4. Regulatory Framework
4.5. Opportunity Matrix
4.6. Vendor Landscape

5. Market By Cell Type
5.1. Stem Cell
5.1.1. Bone Marrow
5.1.2. Blood
5.1.3. Umbilical Cord-Derived Stem Cell
5.1.4. Adipose-Derived Stem Cell
5.1.5. Others
5.2. Non-Stem Cell

6. Market By Therapy Type
6.1. Autologous
6.2. Allogeneic

7. Market By Therapeutic Application
7.1. Malignancies
7.2. Musculoskeletal Disorders
7.3. Autoimmune Disorders
7.4. Dermatology
7.5. Other Applications

8. Market By End-User
8.1. Hospitals & Clinics
8.2. Academic & Research Institutes

9. Geographical Analysis
9.1. Europe
9.1.1. Market Size & Estimates
9.1.2. Key Drivers
9.1.3. Key Challenges
9.1.4. Key Players
9.1.5. Country Analysis
9.1.5.1. United Kingdom
9.1.5.2. Germany
9.1.5.3. France
9.1.5.4. Italy
9.1.5.5. Spain
9.1.5.6. Belgium
9.1.5.7. Poland
9.1.5.8. Rest Of Europe

10. Competitive Landscape
10.1. Key Strategic Developments
10.1.1. Mergers & Acquisitions
10.1.2. Product Launches & Developments
10.1.3. Partnerships & Agreements
10.1.4. Business Expansions
10.2. Company Profiles
10.2.1. Anterogen Co Ltd
10.2.2. Bristol Myers Squibb Company
10.2.3. Cells For Cells Sa
10.2.4. Gilead Sciences Inc
10.2.5. Jcr Pharmaceuticals Co Ltd
10.2.6. Kolon Tissuegene Inc
10.2.7. Medipost Co Ltd
10.2.8. Mesoblast Limited
10.2.9. Nuvasive Inc
10.2.10. Smith & Nephew Plc
10.2.11. Stemedica Cell Technologies Inc
10.2.12. Vericel Corporation



List of Figures

List Of Figures
Figure 1: Key Market Trends
Figure 2: Porter’S Five Forces Analysis
Figure 3: Opportunity Matrix
Figure 4: Vendor Landscape
Figure 5: Europe Cell Therapy Market, Growth Potential, By Cell Type, In 2021
Figure 6: Europe Cell Therapy Market, By Stem Cell, 2022-2030 (In $ Million)
Figure 7: Europe Cell Therapy Market, Growth Potential, By Stem Cell, In 2021
Figure 8: Europe Cell Therapy Market, By Bone Marrow, 2022-2030 (In $ Million)
Figure 9: Europe Cell Therapy Market, By Blood, 2022-2030 (In $ Million)
Figure 10: Europe Cell Therapy Market, By Umbilical Cord-Derived Stem Cell, 2022-2030 (In $ Million)
Figure 11: Europe Cell Therapy Market, By Adipose-Derived Stem Cell, 2022-2030 (In $ Million)
Figure 12: Europe Cell Therapy Market, By Others, 2022-2030 (In $ Million)
Figure 13: Europe Cell Therapy Market, By Non-Stem Cell, 2022-2030 (In $ Million)
Figure 14: Europe Cell Therapy Market, Growth Potential, By Therapy Type, In 2021
Figure 15: Europe Cell Therapy Market, By Autologous, 2022-2030 (In $ Million)
Figure 16: Europe Cell Therapy Market, By Allogeneic, 2022-2030 (In $ Million)
Figure 17: Europe Cell Therapy Market, Growth Potential, By Therapeutic Application, In 2021
Figure 18: Europe Cell Therapy Market, By Malignancies, 2022-2030 (In $ Million)
Figure 19: Europe Cell Therapy Market, By Musculoskeletal Disorders, 2022-2030 (In $ Million)
Figure 20: Europe Cell Therapy Market, By Autoimmune Disorders, 2022-2030 (In $ Million)
Figure 21: Europe Cell Therapy Market, By Dermatology, 2022-2030 (In $ Million)
Figure 22: Europe Cell Therapy Market, By Other Applications, 2022-2030 (In $ Million)
Figure 23: Europe Cell Therapy Market, Growth Potential, By End-User, In 2021
Figure 24: Europe Cell Therapy Market, By Hospitals & Clinics, 2022-2030 (In $ Million)
Figure 25: Europe Cell Therapy Market, By Academic & Research Institutes, 2022-2030 (In $ Million)
Figure 26: Europe Cell Therapy Market, Country Outlook, 2021 & 2030 (In %)
Figure 27: United Kingdom Cell Therapy Market, 2022-2030 (In $ Million)
Figure 28: Germany Cell Therapy Market, 2022-2030 (In $ Million)
Figure 29: France Cell Therapy Market, 2022-2030 (In $ Million)
Figure 30: Italy Cell Therapy Market, 2022-2030 (In $ Million)
Figure 31: Spain Cell Therapy Market, 2022-2030 (In $ Million)
Figure 32: Belgium Cell Therapy Market, 2022-2030 (In $ Million)
Figure 33: Poland Cell Therapy Market, 2022-2030 (In $ Million)
Figure 34: Rest Of Europe Cell Therapy Market, 2022-2030 (In $ Million)

List of Tables

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – CELL THERAPY
TABLE 2: REGULATORY FRAMEWORK
TABLE 3: EUROPE CELL THERAPY MARKET, BY CELL TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 4: EUROPE CELL THERAPY MARKET, BY CELL TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 5: EUROPE CELL THERAPY MARKET, BY STEM CELL, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 6: EUROPE CELL THERAPY MARKET, BY STEM CELL, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 7: EUROPE CELL THERAPY MARKET, BY THERAPY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 8: EUROPE CELL THERAPY MARKET, BY THERAPY TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 9: EUROPE CELL THERAPY MARKET, BY THERAPEUTIC APPLICATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 10: EUROPE CELL THERAPY MARKET, BY THERAPEUTIC APPLICATION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 11: EUROPE CELL THERAPY MARKET, BY END-USER, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 12: EUROPE CELL THERAPY MARKET, BY END-USER, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 13: EUROPE CELL THERAPY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 14: EUROPE CELL THERAPY MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 15: KEY PLAYERS IN EUROPE CELL THERAPY MARKET
TABLE 16: LIST OF MERGERS & ACQUISITIONS
TABLE 17: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 18: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 19: LIST OF BUSINESS EXPANSIONS